[EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)].
Identifieur interne : 000067 ( Main/Exploration ); précédent : 000066; suivant : 000068[EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)].
Auteurs : I. Kötter [Allemagne]Source :
- Zeitschrift fur Rheumatologie [ 1435-1250 ] ; 2009.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Maladie de Behçet.
- normes : Rhumatologie.
- thérapie : Maladie de Behçet.
- Europe, Guides de bonnes pratiques cliniques comme sujet, Humains.
English descriptors
- KwdEn :
- MESH :
- geographic : Europe.
- diagnosis : Behcet Syndrome.
- standards : Rheumatology.
- therapy : Behcet Syndrome.
- Humans, Practice Guidelines as Topic.
Abstract
OBJECTIVES
The aim of the EULAR/ESCISIT initiative was to develop evidence-based recommendations for the management of Behçet's disease (BD), supplemented where necessary by expert opinions and taking already published data into consideration. The current article briefly summarises the results in German and comments on them.
METHODS
The multidisciplinary expert committee consisted of nine rheumatologists, three ophthalmologists, one internist, one dermatologist, and one neurologist, representing six European countries, Tunisia and Korea. One patient representative was also present. Problem areas and related keywords for a systematic literature search were identified. A systematic literature research was performed using MedLine and the Cochrane library up to December 2006. Consequently, 40 initial statements were generated based on the literature research. These yielded the final recommendations which resulted from two blind Delphi rounds of voting.
RESULTS
Nine recommendations were developed for the management of different aspects of BD. The strength of each recommendation was determined by the level of evidence and the expert's opinions. The level of agreement for each recommendation was determined using a visual analogue scale for both the whole committee and for each individual viewpoint of the subgroup, who considered themselves experts in that field of BD. There was excellent concordance between the level of agreement of the whole group and the "experts in the field".
CONCLUSION
Recommendations relating to eye, skin, and mucosal disease, as well as arthritis are mainly evidence-based, while recommendations on vascular disease and neurological and gastrointestinal involvement are based largely on expert opinions and uncontrolled evidence from open trials and observational studies. The need for further properly designed controlled clinical trials is apparent.
DOI: 10.1007/s00393-008-0407-1
PubMed: 19093128
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000755
- to stream PubMed, to step Curation: 000751
- to stream PubMed, to step Checkpoint: 000726
- to stream Main, to step Merge: 000067
- to stream Main, to step Curation: 000067
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)].</title>
<author><name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I" last="Kötter">I. Kötter</name>
<affiliation wicri:level="1"><nlm:affiliation>Bereich Rheumatologie, Medizinische Universitätsklinik Abt. II,Hämatologie, Onkologie, Immunologie, Rheumatologie, Pulmologie, Otfried-Müller-Str. 10, 72076 Tübingen. ina.koetter@med.uni-tuebingen.de</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19093128</idno>
<idno type="pmid">19093128</idno>
<idno type="doi">10.1007/s00393-008-0407-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000755</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000755</idno>
<idno type="wicri:Area/PubMed/Curation">000751</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000751</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000726</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000726</idno>
<idno type="wicri:Area/Main/Merge">000067</idno>
<idno type="wicri:Area/Main/Curation">000067</idno>
<idno type="wicri:Area/Main/Exploration">000067</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)].</title>
<author><name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I" last="Kötter">I. Kötter</name>
<affiliation wicri:level="1"><nlm:affiliation>Bereich Rheumatologie, Medizinische Universitätsklinik Abt. II,Hämatologie, Onkologie, Immunologie, Rheumatologie, Pulmologie, Otfried-Müller-Str. 10, 72076 Tübingen. ina.koetter@med.uni-tuebingen.de</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</analytic>
<series><title level="j">Zeitschrift fur Rheumatologie</title>
<idno type="eISSN">1435-1250</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Behcet Syndrome (diagnosis)</term>
<term>Behcet Syndrome (therapy)</term>
<term>Europe (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Practice Guidelines as Topic (MeSH)</term>
<term>Rheumatology (standards)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Europe (MeSH)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Maladie de Behçet (diagnostic)</term>
<term>Maladie de Behçet (thérapie)</term>
<term>Rhumatologie (normes)</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Europe</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Behcet Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladie de Behçet</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Rhumatologie</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Rheumatology</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Behcet Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Maladie de Behçet</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Europe</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b>
</p>
<p>The aim of the EULAR/ESCISIT initiative was to develop evidence-based recommendations for the management of Behçet's disease (BD), supplemented where necessary by expert opinions and taking already published data into consideration. The current article briefly summarises the results in German and comments on them.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>The multidisciplinary expert committee consisted of nine rheumatologists, three ophthalmologists, one internist, one dermatologist, and one neurologist, representing six European countries, Tunisia and Korea. One patient representative was also present. Problem areas and related keywords for a systematic literature search were identified. A systematic literature research was performed using MedLine and the Cochrane library up to December 2006. Consequently, 40 initial statements were generated based on the literature research. These yielded the final recommendations which resulted from two blind Delphi rounds of voting.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Nine recommendations were developed for the management of different aspects of BD. The strength of each recommendation was determined by the level of evidence and the expert's opinions. The level of agreement for each recommendation was determined using a visual analogue scale for both the whole committee and for each individual viewpoint of the subgroup, who considered themselves experts in that field of BD. There was excellent concordance between the level of agreement of the whole group and the "experts in the field".</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSION</b>
</p>
<p>Recommendations relating to eye, skin, and mucosal disease, as well as arthritis are mainly evidence-based, while recommendations on vascular disease and neurological and gastrointestinal involvement are based largely on expert opinions and uncontrolled evidence from open trials and observational studies. The need for further properly designed controlled clinical trials is apparent.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I" last="Kötter">I. Kötter</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/MaghrebDataLibMedV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000067 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000067 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= MaghrebDataLibMedV2 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:19093128 |texte= [EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19093128" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a MaghrebDataLibMedV2
This area was generated with Dilib version V0.6.38. |